標題: Titlebook: Leukemia Stem Cells in Hematologic Malignancies; Haojian Zhang,Shaoguang Li Book 2019 The Editor(s) (if applicable) and The Author(s), und [打印本頁] 作者: gloomy 時間: 2025-3-21 18:26
書目名稱Leukemia Stem Cells in Hematologic Malignancies影響因子(影響力)
書目名稱Leukemia Stem Cells in Hematologic Malignancies影響因子(影響力)學科排名
書目名稱Leukemia Stem Cells in Hematologic Malignancies網絡公開度
書目名稱Leukemia Stem Cells in Hematologic Malignancies網絡公開度學科排名
書目名稱Leukemia Stem Cells in Hematologic Malignancies被引頻次
書目名稱Leukemia Stem Cells in Hematologic Malignancies被引頻次學科排名
書目名稱Leukemia Stem Cells in Hematologic Malignancies年度引用
書目名稱Leukemia Stem Cells in Hematologic Malignancies年度引用學科排名
書目名稱Leukemia Stem Cells in Hematologic Malignancies讀者反饋
書目名稱Leukemia Stem Cells in Hematologic Malignancies讀者反饋學科排名
作者: 運動性 時間: 2025-3-21 20:49
RNA ,,-Methyladenosine Modification in Normal and Malignant Hematopoiesis,matopoietic stem cells, tissue development, circadian rhythm, heat shock or DNA damage response, and sex determination. Thus, it is not surprising that dysregulation of the m.A machinery is also closely associated with pathogenesis and drug response of both solid tumors and hematologic malignancies.作者: employor 時間: 2025-3-22 02:10 作者: guardianship 時間: 2025-3-22 04:42
DNA Damage Response in Quiescent Hematopoietic Stem Cells and Leukemia Stem Cells,, the DDR of LSCs were summarized based on the major outcomes triggered by different pathways in specific leukemia, upon which some aspects for future investigations were envisioned under our currently limited scope of knowledge.作者: overweight 時間: 2025-3-22 11:08 作者: 尾隨 時間: 2025-3-22 13:27
Lindsay M. Gurska,Kristina Ames,Kira Gritsmane is a widespread problem across all fields of applied science. .Intelligent Tinkering. offers an insightful look at the underlying causes of the problem, along with invaluable suggestions for addressing it..978-1-61091-040-8Series ISSN 2945-5391 Series E-ISSN 2945-5405 作者: gene-therapy 時間: 2025-3-22 17:03 作者: 白楊魚 時間: 2025-3-22 22:27
Dan Huang,Chiqi Chen,Xiaoxin Hao,Hao Gu,Li Xie,Zhuo Yu,Junke Zhenge is a widespread problem across all fields of applied science. .Intelligent Tinkering. offers an insightful look at the underlying causes of the problem, along with invaluable suggestions for addressing it..978-1-61091-040-8Series ISSN 2945-5391 Series E-ISSN 2945-5405 作者: 參考書目 時間: 2025-3-23 02:43
Hengyou Weng,Huilin Huang,Jianjun Chene is a widespread problem across all fields of applied science. .Intelligent Tinkering. offers an insightful look at the underlying causes of the problem, along with invaluable suggestions for addressing it..978-1-61091-040-8Series ISSN 2945-5391 Series E-ISSN 2945-5405 作者: 充滿人 時間: 2025-3-23 07:16
Kanak Joshi,Lei Zhang,Peter Breslin S.J.,Jiwang Zhange is a widespread problem across all fields of applied science. .Intelligent Tinkering. offers an insightful look at the underlying causes of the problem, along with invaluable suggestions for addressing it..978-1-61091-040-8Series ISSN 2945-5391 Series E-ISSN 2945-5405 作者: Heterodoxy 時間: 2025-3-23 09:46
Persio Dello Sbarba,Giulia Chelonie is a widespread problem across all fields of applied science. .Intelligent Tinkering. offers an insightful look at the underlying causes of the problem, along with invaluable suggestions for addressing it..978-1-61091-040-8Series ISSN 2945-5391 Series E-ISSN 2945-5405 作者: Radiation 時間: 2025-3-23 14:43 作者: ADAGE 時間: 2025-3-23 21:22
Jing Xu,Xiaohang Hang,Baohong Wu,Chong Chen,Yu Liue is a widespread problem across all fields of applied science. .Intelligent Tinkering. offers an insightful look at the underlying causes of the problem, along with invaluable suggestions for addressing it..978-1-61091-040-8Series ISSN 2945-5391 Series E-ISSN 2945-5405 作者: 揉雜 時間: 2025-3-24 01:44 作者: constellation 時間: 2025-3-24 02:54 作者: Allure 時間: 2025-3-24 07:36 作者: 喚醒 時間: 2025-3-24 12:24
Cellular and Molecular State of Myeloid Leukemia Stem Cells,malignancies such as chronic myeloid leukemia (CML) and acute myeloid leukemia (AML) are derived from this cell?population. LSCs are also responsible for disease relapse due to its resistance to drug treatment. This rare cell population is phenotypically and functionally heterogeneous. Increasing ev作者: Oscillate 時間: 2025-3-24 16:34 作者: 搖曳的微光 時間: 2025-3-24 19:33
RNA ,,-Methyladenosine Modification in Normal and Malignant Hematopoiesis,transcriptionally regulate expression of thousands of messenger RNA (mRNA) transcripts in each mammalian cell type in a dynamic and reversible manner. This epigenetic mark is deposited by the m.A methyltransferase complex (i.e., the METTL3/METTL14/WTAP complex and other cofactor proteins) and erased作者: 情愛 時間: 2025-3-25 02:00
Leukemia Stem Cells in the Pathogenesis, Progression, and Treatment of Acute Myeloid Leukemia,pt of LSCs have not as yet?been satisfactorily addressed experimentally. As a result, the clinical relevance of LSCs remains less than clear due to controversies caused largely by technical limitations in efficiently identifying LSCs. This has impeded our ability to fully address the features of gen作者: Stricture 時間: 2025-3-25 04:53 作者: FELON 時間: 2025-3-25 08:54
DNA Damage Response in Quiescent Hematopoietic Stem Cells and Leukemia Stem Cells,the maintenance of normal stem cell poor for whole-life blood regeneration and the transformation to leukemia stem cells (LSCs) for leukemia initiation. LSCs also take actions of combating with the attack launched by externally therapeutic drugs that can kill most leukemic cells, to avoid exterminat作者: 脫毛 時間: 2025-3-25 11:56
Epigenetic Abnormalities in Acute Myeloid Leukemia and Leukemia Stem Cells,ulating data suggest that these leukemia-associated epigenetic factors play critical roles in both normal hematopoietic stem cells (HSCs) and leukemia stem cells (LSCs). In turn, these abnormalities result in susceptibilities of LSC and related diseases to epigenetic inhibitors. In this chapter, we 作者: 集聚成團 時間: 2025-3-25 17:36 作者: TIA742 時間: 2025-3-25 22:20
Cellular Immunotherapy in the Treatment of Hematopoietic Malignancies,ion of T cell cytotoxicity against tumors by adoptive cell therapies (ACT), cancer vaccines, gene therapies, and monoclonal antibody therapies has been intensively studied. In particular, immune checkpoint blockade and chimeric antigen receptor T (CAR-T) cell therapies are the recent clinical succes作者: farewell 時間: 2025-3-26 02:04
Lindsay M. Gurska,Kristina Ames,Kira Gritsman discuss and critique the role of formal science in restorat.Robert J. Cabin explores the relationship between science and practice in ecological restoration. Despite the often distinct cultures and methodologies of scientists and practitioners, Cabin shows how each has a vital role in effective res作者: Living-Will 時間: 2025-3-26 05:17 作者: 絆住 時間: 2025-3-26 09:40
Dan Huang,Chiqi Chen,Xiaoxin Hao,Hao Gu,Li Xie,Zhuo Yu,Junke Zheng discuss and critique the role of formal science in restorat.Robert J. Cabin explores the relationship between science and practice in ecological restoration. Despite the often distinct cultures and methodologies of scientists and practitioners, Cabin shows how each has a vital role in effective res作者: 極肥胖 時間: 2025-3-26 16:20 作者: Fillet,Filet 時間: 2025-3-26 19:00 作者: GILD 時間: 2025-3-26 22:20 作者: 昆蟲 時間: 2025-3-27 02:58 作者: 萬神殿 時間: 2025-3-27 06:05 作者: 鬧劇 時間: 2025-3-27 09:59 作者: 解凍 時間: 2025-3-27 15:24 作者: 滔滔不絕地講 時間: 2025-3-27 19:52
Book 2019ic strategies need to be developed by focusing on the complete eradication of LSCs. Given its scope, the book offers a valuable asset for graduate students and scientists in the fields of cell biology and cancer research etc..作者: iodides 時間: 2025-3-27 22:59
Cellular and Molecular State of Myeloid Leukemia Stem Cells,SCs, and the dynamic cross talk between LSCs and bone marrow microenvironment. These specific features of LSCs highlight the dynamic cellular state of LSCs, and further exploring on it might provide potential therapeutic targets that are important for eliminating LSCs.作者: 脫水 時間: 2025-3-28 03:33 作者: falsehood 時間: 2025-3-28 08:01 作者: 無節(jié)奏 時間: 2025-3-28 13:52
Cellular Immunotherapy in the Treatment of Hematopoietic Malignancies,ptor (CAR) T cell therapy, and CAR-T cell clinical trials in leukemia, lymphoma, and multiple myeloma. Clinical trials have shown encouraging results, but future studies may need to incorporate novel CAR constructs or targets with enhanced safety and efficacy to ensure long-term benefits.作者: 不易燃 時間: 2025-3-28 16:06
0065-2598 opoietic malignancies.Covers the molecular signatures of leu.This book introduces readers to the biology of leukemia stem cells (LSCs) and emphasizes the necessity and importance of targeting LSCs in the treatment of hematopoietic malignancies. It addresses the role of leukemia stem cells in differe作者: isotope 時間: 2025-3-28 20:52
